Loading...

Medartis Holding AG

MED.SW•SIX
Healthcare
Medical - Devices
CHF78.30
CHF-0.60(-0.76%)

Medartis Holding AG (MED.SW) Stock Overview

Explore Medartis Holding AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap972.4M
P/E Ratio275.11
EPS (TTM)$0.28
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Week$74.66
1 Month$69.51
3 Months$61.68
1 Year Target$61.54

MED.SW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Medartis Holding AG (MED.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.66, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $61.54.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 275.11 and a market capitalization of 972.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

53.66RSI (14)
0.57MACD
24.58ADX
Stats data is not available for MED.SWStats details for MED.SW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for MED.SWAnalyst Recommendations details for MED.SW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.

CEO

Matthias Schupp

Employees

816

Headquarters

Hochbergerstrasse 60E, Basel

Founded

2018

Frequently Asked Questions

;